20120215-IR-071120072ERA Amends 71 IAC 8-1-4.2 regarding threshold levels. Amends 71 IAC 8.5-1-4.2 regarding threshold levels. Effective February 8, 2012.

TITLE 71 INDIANA HORSE RACING COMMISSION

Emergency Rule LSA Document #12-72(E)

DIGEST

Amends 71 IAC 8-1-4.2 regarding threshold levels. Amends 71 IAC 8.5-1-4.2 regarding threshold levels. Effective February 8, 2012.

71 IAC 8-1-4.2; 71 IAC 8.5-1-4.2

SECTION 1. 71 IAC 8-1-4.2 IS AMENDED TO READ AS FOLLOWS:

71 IAC 8-1-4.2 Threshold levels

Authority: IC 4-31-3-9

Affected: IC 4-31-12

Sec. 4.2. The official blood (serum or plasma) sample may contain the following drug substances, their metabolites or analogs, and shall not exceed the threshold concentrations specified in this rule:

(1) The use of clenbuterol shall be permitted under the following conditions: Not to exceed the following permitted serum or plasma threshold concentrations twenty-five (25) picograms per milliliter of clenbuterol (or its metabolites) which are consistent with administration of FDA approved medication at the recommended labeled dose with a withdrawal time of seven (7) days: Standardbred - 25 picograms per milliliter. in serum or plasma.

(2) The use of firocoxib shall be permitted under the following conditions: Not to exceed forty (40) nanograms per milliliter of firocoxib (or its metabolites) in serum or plasma.

(3) The use of dimethylsulfoxide (DMSO) shall be permitted under the following conditions: Not to exceed ten (10) micrograms per milliliter of DMSO (or its metabolites) in serum or plasma which allows for topical administration of DMSO in accordance with 71 IAC 8-1-1 [section 1 of this rule].

(Indiana Horse Racing Commission; 71 IAC 8-1-4.2; emergency rule filed Jan 25, 2012, 12:20 p.m.: 20120201-IR-071120056ERA; emergency rule filed Feb 8, 2012, 12:01 p.m.: 20120215-IR-071120072ERA)

SECTION 2. 71 IAC 8.5-1-4.2 IS AMENDED TO READ AS FOLLOWS:

71 IAC 8.5-1-4.2 Threshold levels

Authority: IC 4-31-3-9

Affected: IC 4-31-12

Sec. 4.2. The official blood (serum or plasma) sample may contain the following drug substances, their metabolites or analogs, and shall not exceed the threshold concentrations specified in this rule:

(1) The use of clenbuterol shall be permitted under the following conditions:

(1) (A) Not to exceed the following permitted serum or plasma threshold concentrations of clenbuterol (or its metabolites): which are consistent with administration of FDA approved medication at the recommended labeled dose with a withdrawal time of seven (7) days: Thoroughbred – twenty-five (25) picograms per milliliter.

(2) (B) Not to exceed the following permitted serum or plasma threshold concentrations of clenbuterol (or its metabolites): which are consistent with administration of FDA approved medication at the recommended labeled dose with a withdrawal time of thirty (30) days: Quarter horse – two (2) picograms per milliliter.

(2) The use of firocoxib shall be permitted under the following conditions: Not to exceed forty (40) nanograms per milliliter of firocoxib (or its metabolites) in serum or plasma.

(3) The use of dimethylsulfoxide (DMSO) shall be permitted under the following conditions: Not to exceed ten (10) micrograms per milliliter of DMSO (or its metabolites) in serum or plasma which allows for topical administration of DMSO in accordance with 71 IAC 8.5-1-1 [section 1 of this rule].

(Indiana Horse Racing Commission; 71 IAC 8.5-1-4.2; emergency rule filed Jan 25, 2012, 12:20 p.m.: 20120201-IR-071120056ERA; emergency rule filed Feb 8, 2012, 12:01 p.m.: 20120215-IR-071120072ERA)

LSA Document #12-72(E)

Filed with Publisher: February 8, 2012, 12:01 p.m.

Posted: 02/15/2012 by Legislative Services Agency

DIN: 20120215-IR-071120072ERA

Composed: Nov 01,2016 1:19:01AM EDT

A PDF version of this document.